Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors

被引：0
|
作者：
Christina Darden
Mark Price
David Ray
Grace Goldstein
Diana Goss
Lee Bennett
Diana Garbinsky
Ramya Thota
机构：
[1] RTI Health Solutions,Department of Surveys and Observational Studies
[2] Ipsen Biopharmaceuticals,Department of Patient
[3] Inc.,Reported Outcomes
[4] Carcinoid Cancer Foundation,Department of Biometrics
[5] RTI Health Solutions,undefined
[6] RTI Health Solutions,undefined
[7] Intermountain Medical Center,undefined
来源：
Journal of Patient-Reported Outcomes | / 5卷
关键词：
Neuroendocrine tumor; Serial survey; Patient experience; Satisfaction; Interviews; Somatostatin analog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patients' satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
    Darden, Christina
    Price, Mark
    Ray, David
    Goldstein, Grace
    Goss, Diana
    Bennett, Lee
    Garbinsky, Diana
    Thota, Ramya
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2021, 5 (01)
  • [2] Satisfaction Survey of Administration Modes for Long-Acting (La) Somatostatin Analog (SSA) Therapy in Patients With Neuroendocrine Tumors (NET)
    Darden, Christina
    Ray, David
    Goldstein, Grace
    Goss, Diana
    Garbinsky, Diana
    Bennett, Lee
    Price, Mark
    Thota, Ramya
    PANCREAS, 2020, 49 (03) : 466 - 466
  • [3] USE OF LONG-ACTING SOMATOSTATIN ANALOG, LANREOTIDE, IN NEUROENDOCRINE TUMORS
    CANOBBIO, L
    CANNATA, D
    MIGLIETTA, L
    PACE, M
    BOCCARDO, F
    ONCOLOGY REPORTS, 1994, 1 (01) : 129 - 131
  • [4] The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
    Ducreux, M
    Ruszniewski, P
    Chayvialle, JA
    Blumberg, J
    Cloarec, D
    Michel, H
    Raymond, JM
    Dupas, JL
    Gouerou, H
    Jian, R
    Genestin, E
    Hammel, P
    Rougier, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (11): : 3276 - 3281
  • [5] THE USE OF THE LONG-ACTING SOMATOSTATIN ANALOG OCTREOTIDE IN THE TREATMENT OF GUT NEUROENDOCRINE TUMORS
    WYNICK, D
    BLOOM, SR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (01): : 1 - 3
  • [6] COMPLICATIONS OF LONG-ACTING SOMATOSTATIN ANALOG THERAPY
    JACKSON, JA
    AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04): : 512 - 513
  • [7] Satisfaction Survey of Administration Modes for Long-Acting (LA) Somatostatin Analog (SSA) Therapy in Patients (pts) with Neuroendocrine Tumors (NETs): Results of Cognitive Interviews with Patients and Nurses
    Darden, C.
    Ray, D.
    Goldstein, G.
    Goss, D.
    Price, M.
    Thota, R.
    NEUROENDOCRINOLOGY, 2019, 108 : 52 - 52
  • [8] Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
    Clarke, Callisia N.
    Cockrum, Paul
    Beveridge, Thomas J. R.
    Jerry, Michelle
    McMorrow, Donna
    Anh Thu Tran
    Phan, Alexandria T.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (02): : 121 - 131
  • [9] TREATMENT OF ENDOCRINE GASTROINTESTINAL TUMORS WITH A LONG-ACTING SOMATOSTATIN ANALOG
    STOCKMANN, F
    RICHTER, G
    CONLON, JM
    CREUTZFELDT, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1985, 23 (09): : 519 - 519
  • [10] LONG-ACTING SOMATOSTATIN ANALOG FOR PATIENTS WITH GASTRINOMA SYNDROME
    TSAI, ST
    LEWIS, EW
    VINIK, AI
    CLINICAL RESEARCH, 1985, 33 (04): : A876 - A876
12345